Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology.
Gene Biotherapeutics (formerly known as Taxus Cardium Pharmaceuticals and Cardium Therapeutics) is a company that manages a portfolio of medical technologies.
The Cell and Gene Therapy Catapult (Cell Therapy Catapult) is a part of Catapult nationwide-network of technology centres operating in the cell and gene therapy industry.
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.